Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

997120

registered interest
date	29/10/2018
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Aviation: Compensation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, if he will bring forward legislative proposals to provide for the automatic provision of compensation in the event of a delayed flight.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184961
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>There are no plans at present to legislate for automatic compensation for delayed flights. As part of the Aviation Strategy that is currently under development, The Government will consider how to simplify the compensation claim process for consumers.</p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 02/11/2018 12:23:15 answering member 3991 label Biography information for Jesse Norman
tabling member	4131 label Biography information for Jim Shannon

994495

registered interest
date	25/10/2018
answering body	Northern Ireland Office
answering dept id	21
answering dept short name	Northern Ireland
answering dept sort name	Northern Ireland
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Northern Ireland, if he will discuss with the Secretary of State for Health and Social Care the potential merits of introducing the HPV vaccination programme for boys in Northern Ireland.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	183934
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>Health is a devolved matter in Northern Ireland. The honourable Member may find it useful to refer to the answer I gave on 29 October which confirms that preparatory work is underway within the Department of Health in Northern Ireland to allow for the introduction of HPV to boys in Northern Ireland, if and when such a decision is taken by a Health Minister in Northern Ireland. This approach reflects the fact that health policy is devolved in Northern Ireland and so the decision whether to introduce the HPV vaccine for boys is one for Northern Ireland Ministers to take.</p> answering member constituency North West Cambridgeshire answering member printed Mr Shailesh Vara question first answered 01/11/2018 15:22:40 answering member 1496 label Biography information for Shailesh Vara
tabling member	4131 label Biography information for Jim Shannon

994496

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tramadol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to limit the prescription of Tramadol.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	183935
answer	answer is ministerial correction date of answer 31/10/2018 answer text <p>The Department expects all clinicians to act responsibly when prescribing schedule three drugs such as Tramadol. The responsibility for prescribing and any necessary follow-up rests with the doctor or prescriber who has clinical responsibility for that particular aspect of a patient's care. Decisions on which drugs are prescribed should be based on clinical assessments. Good communication between practitioners and patients is essential and prescribers should always involve patients in decisions about the treatment proposed, including informing them of any possible side effects from their prescribed medicines.</p><p> </p><p>The Advisory Council on the Misuse of Drugs published advice on the use of Tramadol in 2013. This advice can be found at the following link:</p><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/144116/advice-tramadol.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/144116/advice-tramadol.pdf</a></p><p> </p><p>Advice to prescribers includes warnings that repeated use is associated with psychological and physical dependence.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 31/10/2018 12:09:42 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

994691

registered interest
date	25/10/2018
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Borders: ICT
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, what steps he is taking to ensure that all 12 of the critical IT systems required at the border are ready in the event that the UK leaves the EU on 29 March 2019 without a deal.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	183938
answer	answer is ministerial correction date of answer 01/11/2018 answer text <p>All of the 12 critical IT systems are subject to close scrutiny within departments, alongside scrutiny by the Border Delivery Group and the Infrastructure and Projects Authority where applicable.</p><p> </p><p>For programmes where there are delivery risks, departments have mitigation plans to address the risks, and have ensured there are appropriate contingency plans in place.</p> answering member constituency Central Devon answering member printed Mel Stride question first answered 01/11/2018 17:29:03 answering member 3935 label Biography information for Mel Stride
tabling member	4131 label Biography information for Jim Shannon

992638

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Postnatal Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 May 2018 to Question 142448 on Postnatal Care, whether the General Medical Services contract sets out that GPs must provide the (a) six week postnatal check for new mothers and (b) six to eight week check for babies.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182198
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>A six-week postnatal check for all mothers and a six to eight-week check for all babies are not currently specified in the General Medical Services contract as something which general practitioners are required to provide. However, we have asked for the six-week maternal postnatal check, as recommended by the National Childbirth Trust, to be considered in the general practice contract negotiations for 2019/20.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/10/2018 15:53:20 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992639

registered interest
date	22/10/2018
answering body	Northern Ireland Office
answering dept id	21
answering dept short name	Northern Ireland
answering dept sort name	Northern Ireland
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Northern Ireland, what the timeframe is for a decision to be made on extending HPV vaccination to adolescent boys in Northern Ireland.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182199
answer	answer is ministerial correction date of answer 29/10/2018 answer text <p>A decision regarding whether or not to extend the HPV to boys would normally be taken by a Health Minister in Northern Ireland, primarily because of the long-term financial commitments involved. I understand the Department of Health in Northern Ireland intends to keep this position under review.</p><p> </p><p>Following the JCVI statement published in July, the Department of Health in Northern Ireland is now undertaking preparatory work to allow for the introduction of HPV to boys in Northern Ireland, if such a decision is taken.</p><p> </p> answering member constituency North West Cambridgeshire answering member printed Mr Shailesh Vara question first answered 29/10/2018 15:18:40 answering member 1496 label Biography information for Shailesh Vara
tabling member	4131 label Biography information for Jim Shannon

992640

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to assess the effect of NICE’s Highly Specialised Technologies process on patients in the UK with rare diseases.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182200
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>To date, the National Institute for Health and Care Excellence (NICE) has recommended all eight medicines that it has evaluated through its highly specialised technologies (HST) programme for some or all of the eligible patient population, in most cases subject to managed access agreements that specify clinical criteria and data collection requirements. National Health Service organisations are legally required to fund medicines recommended in NICE’s HST guidance, and patients with the rare diseases concerned are now benefitting from access to the medicines in line with NICE’s recommendations.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 182202 question first answered 30/10/2018 15:52:26 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992641

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether treatments for rare diseases approved under the Highly Specialised Technologies (HST) process would have been rejected under the new criteria introduced for the HST process in 2017.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182201
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>The National Institute for Health and Care Excellence has advised that prior to the revised methods for the development of highly specialised technology (HST) evaluation guidance being introduced in 2017, the HST programme did not have a cost-effectiveness framework to inform the consideration of value for money. Therefore it is not possible to confirm if those technologies that were evaluated before April 2017 would have been recommended under the new methods, because the key elements of the new methods were not established and were not considered by the committee in the context of the many other factors taken into account in the decision-making.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/10/2018 15:49:43 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992642

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of the (a) criteria used for and (b) long term data collection requirement of the highly specialised technologies process.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182202
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>To date, the National Institute for Health and Care Excellence (NICE) has recommended all eight medicines that it has evaluated through its highly specialised technologies (HST) programme for some or all of the eligible patient population, in most cases subject to managed access agreements that specify clinical criteria and data collection requirements. National Health Service organisations are legally required to fund medicines recommended in NICE’s HST guidance, and patients with the rare diseases concerned are now benefitting from access to the medicines in line with NICE’s recommendations.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 182200 question first answered 30/10/2018 15:52:26 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

992643

registered interest
date	22/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many successful applications there have been (a) to NHS England’s individual funding requests for specialised services and (b) through the clinically critically urgent criteria process since January 2018.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	182203
answer	answer is ministerial correction date of answer 30/10/2018 answer text <p>The number of successful individual funding requests since January 2018 is less than 10, and the true figure has been withheld to protect patient confidentiality. The critically urgent criteria process and decision making ceased on publication of the Specialised Commissioning Service Development Policy, which was published by NHS England on 12 September 2017.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 30/10/2018 15:56:29 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon